TNYA Stock Summary and Trading Ideas (Tenaya Therapeutics | NASDAQ:TNYA)

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Tenaya Therapeutics trades on the NASDAQ stock market under the symbol TNYA.

As of April 2, 2026, TNYA stock price declined to $0.66 with 413,181 million shares trading.

TNYA has a beta of 1.98, meaning it tends to be more sensitive to market movements. TNYA has a correlation of 0.07 to the broad based SPY ETF.

TNYA has a market cap of $143.22 million. This is considered a Micro Cap stock.

In the last 3 years, TNYA traded as high as $8.09 and as low as $.36.

The top ETF exchange traded funds that TNYA belongs to (by Net Assets): VTI, IBB, VXF, PRFZ, IBBQ.

TNYA has outperformed the market in the last year with a return of +21.3%, while the SPY ETF gained +17.2%. However, in the most recent history, TNYA shares have underperformed the stock market with its stock returning -7.2% in the last 3 month period and -19.8% for the last 2 week period, while SPY has returned -4.4% and -1.5%, respectively.

TNYA support price is $.63 and resistance is $.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TNYA shares will trade within this expected range on the day.